Overview

Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare the within-subject variability of the pharmacokinetic profiles of insulin detemir and insulin glargine in children and adolescents with type 1 diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin Glargine
Insulin, Globin Zinc